Boza ML[au] - Search Results

Year	Number of Results
2001	2
2005	1
2009	1
2011	1
2014	1
2015	1
2018	2
2023	0

1

Safety and tolerability of montelukast in placebo-controlled pediatric studies and their open-label extensions.

Bisgaard H, Skoner D, Boza ML, Tozzi CA, Newcomb K, Reiss TF, Knorr B, Noonan G. Bisgaard H, et al. Among authors: boza ml. Pediatr Pulmonol. 2009 Jun;44(6):568-79. doi: 10.1002/ppul.21018. Pediatr Pulmonol. 2009. PMID: 19449366 Review.

2

Intermittent or daily montelukast versus placebo for episodic asthma in children.

Valovirta E, Boza ML, Robertson CF, Verbruggen N, Smugar SS, Nelsen LM, Knorr BA, Reiss TF, Philip G, Gurner DM. Valovirta E, et al. Among authors: boza ml. Ann Allergy Asthma Immunol. 2011 Jun;106(6):518-26. doi: 10.1016/j.anai.2011.01.017. Epub 2011 Mar 4. Ann Allergy Asthma Immunol. 2011. PMID: 21624752 Clinical Trial.

3

[Characterization of the physical capacity in children of the Chilean National Program of Cystic Fibrosis].

Puppo H, Von Oetinger A, Benz E, Torres-Castro R, Zagolín M, Boza ML, Astorga L, Bozzo R, Jorquera P, Kogan R, Perillán J. Puppo H, et al. Among authors: boza ml. Rev Chil Pediatr. 2018 Oct;89(5):638-643. doi: 10.4067/S0370-41062018005000812. Rev Chil Pediatr. 2018. PMID: 30571807 Free article. Spanish.

4

Autoimmune pulmonary proteinosis in a Chilean teenager, a rare aetiology of interstitial lung disease.

Strickler A, Boza ML, Koppmann A, Gonzalez S. Strickler A, et al. Among authors: boza ml. BMJ Case Rep. 2014 May 23;2014:bcr2012006987. doi: 10.1136/bcr-2012-006987. BMJ Case Rep. 2014. PMID: 24859540 Free PMC article.

5

[Pediatric non-invasive ventilation for acute respiratory failure in an Intermediate Care Unit].

Prado F, Godoy MA, Godoy M, Boza ML. Prado F, et al. Among authors: boza ml. Rev Med Chil. 2005 May;133(5):525-33. doi: 10.4067/s0034-98872005000500003. Epub 2005 Jun 17. Rev Med Chil. 2005. PMID: 15970976 Free article. Spanish.

6

Bone mineral density, lung function, vitamin D and body composition in children and adolescents with cystic fibrosis: a multicenter study.

Bravo M P, Balboa P, Torrejón C, Bozzo R, Boza ML, Contreras I, Jorquera P, Astorga L, Weisstaub G. Bravo M P, et al. Among authors: boza ml. Nutr Hosp. 2018 Jun 28;35(4):789-795. doi: 10.20960/nh.1609. Nutr Hosp. 2018. PMID: 30070865 Free article.

7

Pro-Inflammatory Cytokines in Nasopharyngeal Aspirate From Hospitalized Children With Respiratory Syncytial Virus Infection With or Without Rhinovirus Bronchiolitis, and Use of the Cytokines as Predictors of Illness Severity.

Díaz PV, Valdivia G, Gaggero AA, Bono MR, Zepeda G, Rivas M, Uasapud P, Pinto RA, Boza ML, Guerrero J. Díaz PV, et al. Among authors: boza ml. Medicine (Baltimore). 2015 Sep;94(39):e1512. doi: 10.1097/MD.0000000000001512. Medicine (Baltimore). 2015. PMID: 26426613 Free PMC article.

8

[Identification of mutation in the gene cystic fibrosis transmembrane regulator (CFTR) in Chilean patients with cystic fibrosis].

Repetto G, Poggi H, Harris P, Navarro H, Sánchez I, Guiraldes E, Pérez MA, Boza ML, Hunter B, Wevar ME, Mediavilla M, Foradori A. Repetto G, et al. Among authors: boza ml. Rev Med Chil. 2001 Aug;129(8):841-7. Rev Med Chil. 2001. PMID: 11680956 Spanish.

9

Montelukast dose selection in children ages 2 to 5 years: comparison of population pharmacokinetics between children and adults.

Knorr B, Nguyen HH, Kearns GL, Villaran C, Boza ML, Reiss TF, Rogers JD, Zhang J, Larson P, Spielberg S. Knorr B, et al. Among authors: boza ml. J Clin Pharmacol. 2001 Jun;41(6):612-9. doi: 10.1177/00912700122010492. J Clin Pharmacol. 2001. PMID: 11402629 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results